Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.
Shehan previously served for over 19 years as general counsel of Novo Nordisk and most recently was of counsel at Hyman, Phelps & McNamara, an FDA regulatory law boutique firm in Washington, D.C. Early in his career, Shehan also worked as corporate counsel at Pfizer and at FDA.
